Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer (NCT01810913) | National Cancer Institute (NCI) | 2013-03-22 |
Track Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.